Arizona Laws & Regulations
The information contained on this website is provided for informational purposes only and should not be construed as legal advice on any matter. The Information constitutes general information of applicable administrative regulation and/or laws related to general topics in the arena of controlled substance misuse and abuse and may not reflect current legal developments and updates. Please refer to your state legislature for any potential changes.
Menu
Arizona Administrative Code (AAC) Link
Arizona Revised Statutes (ARS) Link
Arizona Advertising/Marketing Information
- ARS §13-3415(C) – Possession, manufacture, delivery and advertisement of drug paraphernalia; classification; civil forfeiture; factors; definitions
- ARS §32-1901(2) – Definitions
- ARS §32-1997 – Misbranding: promotion of off-label use
- ARS §36-2859 – Advertising restrictions; enforcement; civil penalty
- Title 21 USC §843 – Communication facility and advertisement
Arizona Child Safety Information
- ARS §36-697 – Health start program; administration
- ARS §8-882 – Program development
- ARS §8-883 – Requirements for contractors
- ARS §8-884 – Evaluation of community programs
Arizona Compounding Information
- ARS §32-1961 – Limit on Dispensing, compounding and sale of drugs
- USP 797 – Pharmaceutical Compounding
Arizona Coroner/Medical Examiner Information
- ARS §11-591 – Definitions
- ARS §11-592 – County medical examiner; alternate medical examiners; fund; notification
- ARS §11-593 – Reporting of certain deaths; failure to report; violations
- ARS §11-594 – Powers and duties of county medical examiner
- ARS §11-597 – Autopsies; reports; exemption from liability
- CDC – Arizona Coroner/Medical Examiner Laws
Arizona Drug Checking Information
- ARS §13-3415(F)(2) – Possession, manufacture, delivery and advertisement of drug paraphernalia; classification; civil forfeiture; factors; definitions
Arizona Drug Cleanup Information
- AZ Courts – Fentanyl and Toxic Evidence Task Force
- AZ Courts – Administrative Order 2022-62 – Establishment of a Task Force to Create Guidelines for the Handling of Fentanyl Evidence and Other Toxic Evidence in the Courthouse
Arizona Drug Court Information
- ARS §13-3422 – Drug court program; establishment; participation
Arizona Drug Free Workplace Information
- Arizona Department of Child Safety – Drug Free Workplace (2018)
- ARS §23-493 – Definitions
- ARS §23-493.04 – Testing Policy Requirements
- ARS §23-493.05 – Disciplinary procedures
Arizona Drugged Driving Information
- ARS §28-1381 – Driving or actual physical control while under the influence; trial by jury; presumptions; admissible evidence; sentencing; classification
- ARS §28-1382 – Driving or actual physical control while under the extreme influence of intoxicating liquor; trial by jury; sentencing; time limitation; violation; classification
- ARS §28-1383 – Aggravated driving or actual physical control while under the influence; county jail program; annual report; violation; classification; definitions
- ARS §28-1384 – Aggravated driving or actual physical control while under the influence; forfeiture of vehicle
- ARS §28-1385 – Administrative license suspension for driving under the influence or for homicide or assault involving a motor vehicle; report; hearing; summary review; ignition interlock device requirement
- ARS §28-1386 – Operating a motor vehicle, aircraft, watercraft or water skis under the influence; emergency response costs; definitions
Arizona Drug Violation(s) Information
- HB2045 – dangerous drugs; definition; xylazine – Signed by Gov 4/8/24 – Chapter 85
- SB1614 – fentanyl; threshold amount; one pill (pending 2024)
- ARS §13-901.01 – Probation for persons convicted of possession or use of controlled substances or drug paraphernalia; treatment; prevention; education; exceptions; definition
- ARS §13-901.02 – Drug Treatment & Education Fund
- ARS § 13-1105(A)(2) – First degree murder: classification
- ARS §13-1205 – Unlawfully administering intoxicating liquors, narcotic drug or dangerous drug; classification
- ARS §13-1308 – Trafficking of persons for forced labor or services; classification; definitions
- ARS §13-3401 – Definitions
- ARS §13-3405 – Possession, use, production, sale or transportation of marijuana; classification
- ARS §13-3406 – Possession, use, administration, acquisition, sale, manufacture or transportation of prescription-only drugs; misbranded drugs; classification; definition
- ARS §13-3407 – Possession, use, administration, acquisition, sale, manufacture or transportation of dangerous drugs; classification
- ARS §13-3407.01 – Manufacturing methamphetamine under circumstances that cause physical injury to a minor; classification
- ARS §13-3408 – Possession, use, administration, acquisition, sale, manufacture or transportation of narcotic drugs; classification; exceptions
- ARS §13-3409 – Involving or using minors in drug offenses; classification
- ARS §13-3410 – Serious drug offender; sentencing; definitions
- ARS §13-3411 – Possession, use, sale or transfer of marijuana, peyote, prescription drugs, dangerous drugs or narcotic drugs or manufacture of dangerous drugs in a drug free school zone; violation; classification; definitions
- ARS §13-3412.01 – Prescribing controlled substances included in schedule I for seriously ill and terminally ill patients
- ARS §13-3414 – Convicted person’s information to be sent to licensing board and the department of economic security; suspension or revocation of license or registration
- ARS §13-3415 – Possession, manufacture, delivery and advertisement of drug paraphernalia; classification; civil forfeiture; factors; definitions
- ARS §13-3419 – Multiple drug offenses not committed on the same occasion; sentencing
- ARS §13-3420 – Unlawful substances; threshold amounts
- ARS §13-3421 – Using building for sale or manufacture of dangerous or narcotic drugs; fortification of a building; classification; definitions
- ARS §13-3422 – Drug court program; establishment; participation
- ARS §13-3451 – Definition
- ARS §13-3452 – Effect of representations made in construing status of certain substances whose origin is uncertain
- ARS §13-3453 – Manufacture or Distribution of Imitation Controlled Substance: Prohibited Acts
- ARS §13-3454 – Manufacture or distribution of imitation prescription only drug; prohibited acts; classification
- ARS §13-3455 – Manufacture or distribution of imitation over-the-counter drug; prohibited acts; classification
- ARS §13-3456 – Possession or possession with intent to use imitation controlled substance; violation; classification
- ARS §13-3457 – Possession or possession with intent to use an imitation prescription only drug; violation; classification
- ARS §13-3458 – Possession or possession with intent to use an imitation over-the-counter drug; violation; classification
- ARS §13-3459 – Manufacture of certain substances and drugs by certain means; prohibited acts; classification
- ARS §13-3730 – Unlawful patient brokering: classification; definition
- ARS §32-1965 – Prohibited acts
- ARS §32-1966 – Acts constituting adulteration of a drug or device
- ARS §32-1967 – Acts constituting misbranding of a drug or device; exceptions; interpretation of misleading label; definition
- ARS §32-1968 – Dispensing prescription-only drug; prescription orders; refills; labels; misbranding; dispensing soft contact lenses; opioid antagonists
- ARS §32-1978 – Sale of dextromethorphan; age requirement; exception; violation; civil penalty; definitions
- ARS §36-1661 – Placing or leaving injurious drug or substance about habitation; classification
- ARS §36-2531 – Prohibited acts; classification
- KRATOM PRODUCTS
- ARS §36-795 – Definitions
- ARS §36-795.01 – Kratom product disclosure; preparing, distributing, selling or exposing for sale without disclosure prohibited
- ARS §36-795.02 – Kratom products; adulteration; contamination; sales to minors prohibited
- ARS §36-795.03 – Enforcement; violations; classification
Arizona Electronic Prescribing Information
- ARS 36-2525 – Prescription orders: labels; packaging: definition
Arizona First Responder Deflection Program(s) Information
- ARS §9-500.22 – Prosecution diversion programs
- ARS §11-361 et seq. – Deferred Prosecution Programs
Arizona 911 – Good Samaritan Information
- Arizona Department of Child Safety – Drug Free Workplace (2018)
- ARS §13-3423 – Medical assistance requests; prohibited prosecution of Good Samaritans; mitigating factor; definitions
- ARS §32-1471 – Health care provider and any other person; emergency aid; non-liability
- ARS §36-2263– Civil liability; limited immunity; Good Samaritan
- ARS §36-2266 – Prescribing and dispensing; immunity; definition
- ARS §36-2267 – Administration of opioid antagonist; exemption from civil liability; definition
Arizona Medical Marijuana, Recreational Marijuana & CBD Information
- AAC R9-17-101 to AAC R9-17-411 – Arizona Administrative Code – Medical Marijuana Program
- ARS §32-1501(31) – Definitions; Unprofessional Conduct Naturopathic Medicine
- ARS §32-3215 – Medical marijuana; unprofessional conduct; annual reports; identifying information
- ARS §36-2801 – Definitions
- ARS §36-2801.01 – Addition of debilitating medical conditions
- ARS §36-2802 – Arizona Medical Marijuana Act; limitations
- ARS §36-2803 – Rulemaking; notice
- ARS §36-2804 – Registration and certification of nonprofit medical marijuana dispensaries
- ARS §36-2804.01 – Registration of nonprofit medical marijuana dispensary agents; notices; civil penalty; classification
- ARS §36-2804.02 – Registration of qualifying patients and designated caregivers
- ARS §36-2804.03 – Issuance of registry identification cards
- ARS §36-2804.04 – Registry identification cards
- ARS §36-2804.05 – Denial of registry identification card
- ARS §36-2804.06 – Expiration and renewal of registry identification cards and registration certificates; replacement
- ARS §36-2805 – Facility restrictions
- ARS §36-2806 – Registered nonprofit medical marijuana dispensaries; requirements
- ARS §36-2806.01 – Dispensary locations
- ARS §36-2806.02 – Dispensing marijuana for medical use
- ARS §36-2807 – Verification system
- ARS §36-2808 – Notifications to department; civil penalty
- ARS §36-2809 – Annual report
- ARS §36-2810 – Confidentiality
- ARS §36-2811 – Presumption of medical use of marijuana; protections; civil penalty
- ARS §36-2813 – Discrimination prohibited
- ARS §36-2814 – Acts not required; acts not prohibited
- ARS §36-2815 – Revocation
- ARS §36-2816 – Violations; civil penalty; classification
- ARS §36-2817 – Medical marijuana fund; private donations
- ARS §36-2818 – Enforcement of this act; mandamus
- ARS §36-2819 – Fingerprinting requirements
-
RESPONSIBLE ADULT USE OF MARIJUANA (Sec: 36-2850-36-2865)
Arizona Medication Assisted Treatment (MAT) Information
- AAC § R9-10-1020 – Opioid Treatment Services
- ARS §32-1491 – Dispensing of drugs and devices; exception; civil penalty; conditions; definition
- ARS §32-3201.01 – Definition of medication-assisted treatment
- ARS §36-2907.14 – AHCCCS; contractors; opioid treatment programs; reimbursement; report; definitions
- ARS §36-2907.15 – Opioid use disorder treatment; standards; centers of excellence; annual report
- ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
- SAMSHA – Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants
- SAMSHA – Statutes, Regulations, And Guidelines
Arizona Naloxone Information
- ARS §32-1968 – Dispensing prescription-only drug; prescription orders; refills; labels; misbranding; dispensing soft contact lenses; opioid antagonists
- ARS §32-1979 – Pharmacists; dispensing opioid antagonists without a prescription; board protocols; immunity
- ARS §36-192 – County health departments; naloxone kits
- ARS §36-798.51 – Overdose and disease prevention programs; requirements; standards
- ARS §36-2228 – Administration of opioid antagonists; training; immunity; designation by director
- ARS §36-2266 – Prescribing and dispensing; immunity; good faith statement; definition
- ARS §36-2267 – Administration of opioid antagonist; exemption from civil liability; definition
Arizona Needle Exchange Programs (NEP) & Syringe Services programs (SSP) Information
- ARS §36-798.51 – Overdose and disease prevention programs; requirements; standards
- ARS §36-798.52 – Immunity
Arizona Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Information
- ARS §13-3620 – Duty to report abuse, physical injury, neglect and denial or deprivation of medical or surgical care or nourishment of minors; medical records; exception; violation; classification; definitions
- Opioid Epidemic – Reporting (ADHS)
- Neonatal Abstinence Syndrome (NAS) Case Definition – ADHS 2018
Arizona Opioid Litigation Proceeds Information
- AZ Attorney General – Arizona Opioid Settlement Information
- One AZ Opioid Settlement Memorandum of Understanding
Arizona Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIF) Information
- NO STATE LAWS OR REGULATIONS IDENTIFIED
Arizona Overdose Surveillance/Reporting Information
- Executive Order 2017-04 – Enhanced Surveillance Advisory (June 13, 2017)
- AAR R9-4-601 & R9-4-602 (Final Rule)
- ARS §36-123 – Opioid abuse prevention campaign
- ARS §36-123.01 – Drug disposal education and awareness; controlled substances; public-private partnership; fund
- ARS §36-198 – Drug overdose fatality review team; members; duties; local drug overdose fatality review teams
- ARS §36-198.01 – Access to information; confidentiality; violation; classification
- ARS §36-782 – Enhanced Surveillance Advisory
- ARS §36-783 – Increased reporting during enhanced surveillance advisory
- ARS §36-784 – Patient tracking during enhanced surveillance advisory
- ARS §36-785 – Information sharing during an enhanced surveillance advisory
- HB 2194 – Drug overdose fatality review teams – Signed by Gov 4/17/2023 – Chapter 56
- Opioid Epidemic – Enhanced Surveillance Reporting Requirements & Data
- Opioid Reporting FAQ – AZ Department of Health Services (ADHS) – 2018
Arizona Pain Management Information
- HB 2075 – Arizona Opioid E-Prescribing Requirement (eff 1/1/2020)
- Opioid Prescribing & Treatment Rules – FAQ
- AAR R9-10-120 – Opioid Prescribing & Treatment
- ARS §23-1062.02 – Off-label and prescription use of controlled substances; prescription of schedule II controlled substances; reports; treatment plans; monitoring program inquiries; preauthorizations; definitions
- ARS §32-3248 – Health professionals; controlled substances; initial prescriptions; limits; exceptions; definition
- ARS §32-3248.01 – Schedule II controlled substances; dosage limit; exceptions; morphine; opioid antagonist; definitions
- ARS §32-3248.02 – Health professionals; substance use or addiction continuing education
- ARS §32-3248.03 – Health professionals; hospitals; dispensing controlled substances; opioids; definition
- ARS §36-448.01 – Definitions
- ARS §36-448.02 -Pain management clinics; licensure requirements; rules
- ARS §36-2606 – Registration; access; requirements; mandatory use; annual user satisfaction survey; report; definitions
- Arizona Guidelines for Dispensing Controlled Substances (2013)
- Arizona Guidelines for Emergency Department Controlled Substances Prescribing – one page summary
- Arizona Guidelines for Emergency Department Controlled Substances Prescribing – full report
- Arizona Opioid Prescribing Guidelines 2018 (Updated 2019)
- Arizona OAR Line: Opioid Assistance and Referral Line
Arizona Pill Press & Counterfeit Medication Information
- ARS §13-3451 – Definitions
- ARS §13-3452 – Effect of representations made in construing status of certain substances whose origin is uncertain
- ARS §13-3453 – Manufacture or distribution of imitation controlled substance; prohibited acts; classification
- ARS §13-3454 – Manufacture or distribution of imitation prescription-only drug; prohibited acts; classification
- ARS §13-3455 – Manufacture or distribution of imitation over-the-counter drug; prohibited acts; classification
- ARS §13-3456 – Possession or possession with intent to use imitation controlled substance; violation; classification
- ARS §13-3457 – Possession or possession with intent to use an imitation prescription-only drug; violation; classification
- ARS §13-3458 – Possession or possession with intent to use an imitation over-the-counter drug; violation; classification
- ARS §13-3459 – Manufacture of certain substances and drugs by certain means; prohibited acts; classification
- ARS §32-1965 – Prohibited Acts
- ARS §32-1993 – Authorization to seize certain drugs, counterfeit drugs and equipment; disposition of seized equipment
Arizona Prescription Drug Drop-Off Information
- ARS §9-500.45 – Drug disposal programs; business assessments prohibited; restrictions; state preemption; definition
- ARS §11-269.26 – Drug disposal programs; business assessments prohibited; restrictions; state preemption; definition
- ARS §36-123.01 – Drug disposal education and awareness; controlled substances; public-private partnership; fund
Arizona Prescription Drug Importation Information
- NO STATE LAWS OR REGULATIONS IDENTIFIED
Arizona Prescription Monitoring Program Information
- ARS §36-2602 – Controlled substances prescription monitoring program; contracts; retention and maintenance of records
- ARS §36-2603 – Computerized central database tracking system task force; membership
- ARS §36-2604 – Use and release of confidential information
- ARS §36-2606 – Registration; access; renewal; requirements; mandatory use; annual user satisfaction survey; report; definition
- ARS §36-2607 – Disciplinary action
- ARS §36-2608 – Reporting requirements; waiver; exceptions
- ARS §36-2609 – Use of information; civil immunity
- ARS §36-2610 – Prohibited acts; violation; classification
Arizona Precursor Chemicals/Including Pseudoephedrine Information
- ARS §13-3404 – Sale of precursor or regulated chemicals; report; exemptions; violation; classification
- ARS §13-3404.01 – Possession or sale of precursor chemicals, regulated chemicals, substances or equipment; exceptions; classification
- ARS §13-3407 – Possession, use, administration, acquisition, sale, manufacture or transportation of dangerous drugs; classification
- ARS §13-3407.01 – Manufacturing methamphetamine under circumstances that cause physical injury to a minor: classification
- ARS §13-3623 – Child or vulnerable adult abuse; emotional abuse; classification; exceptions; definitions
- ARS §32-1977 – Sale of methamphetamine precursors; electronic sales tracking system; violation; classification; state preemption
Arizona Prison Program(s) Information
- Arizona Department of Corrections Rehabilitation and Reentry (2021)
- US DOJ – Residential Substance Abuse Treatment for State Prisoners (RSAT) Program
Arizona School Programs/Information
- ARS §13-901.02 – Drug treatment and education fund
- ARS §41-1604.17 – Arizona parents commission on drug education and prevention
Arizona Sober Living Homes/Recovery Housing Information
- 9 AAC 12 – Department of Health Services Sober Living Homes
- ARS §36-2061 – Definitions
- ARS §36-2062 – Licensure; standards; civil penalties; inspections; use of title
- ARS §36-2063 – Fees; licensure; inspections; complaints; investigation; civil penalty; sanctions
- ARS §36-2064 – Certified sober living homes
- ARS §36-2065 – Referrals; certified or licensed sober living homes
- ARS §36-2066 – Posting; confidential information
- ARS §36-2067 – Department; annual report
Arizona Substance Abuse Services Information
- ARS §32-1452 – Substance abuse treatment and rehabilitation; confidential program; private contract; funding; license restrictions; immunity (Doctors, etc.)
- ARS §32-1932.01 – Substance abuse treatment and rehabilitation program; private contract; funding (pharmacists, etc.)
- ARS §36-109 – Hospitals; health care facilities; substance abuse treatment; reporting requirements
- ARS §36-2001 – Addictive behavior services
- ARS §36-2003 – Powers and duties
- ARS §36-2004 – Designation to administer state plan
- ARS §36-2005 – Substance abuse services fund; purpose; administration
- ARS §36-2006 – Department of health services monitoring of screening, education and treatment programs
- ARS §36-2930.05 – Substance use disorder services fund; AHCCCS administration; use of monies
- ARS §46-300.05 – Substance abuse treatment
Arizona Telemedicine/Telehealth Information
- ARS §20-1057.13 – Telehealth; coverage of health care services; definition
- ARS §32-3248.01 – Schedule II controlled substances; dosage limit; exceptions; morphine; opioid antagonist
- ARS §36-3601 – Definitions
- ARS §36-3602 – Delivery of health care through telemedicine; requirements; exceptions
- ARS §36-3603 – State jurisdiction; scope
- ARS §36-3604 – Use of telemedicine for abortion prohibited; penalty; definition
- ARS §36-3605 – Health care providers; determination of telehealth medium
- ARS §36-3606 – Interstate telehealth services; registration; requirements; venue; exceptions
- ARS §36-3607 – Telehealth advisory committee on telehealth best practices; membership; reports
- ARS §36-3608 – Health care provider regulatory boards and agencies; out-of-state health care providers; reports
Last updated 6/22/2024
Please report any broken links to tech@naddi.org